SERES THERAPEUTICS INC (MCRB) Stock Cash Flow
NASDAQ:MCRB - Nasdaq - US81750R1023 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.48M | -113.72M | -250.16M | -65.58M | -89.13M | |||
| Depreciation Amortization | 6.03M | 6.24M | 6.63M | 5.95M | 6.58M | |||
| Change In Working Capital | -50.76M | -58.98M | -18.39M | 41.53M | -23.20M | |||
| Interest Paid | 14.40M | 12.55M | 4.93M | 2.45M | 2.45M | |||
| Other non cash items | -87.00M | 49.10M | 33.10M | 24.79M | 12.14M | |||
| OPERATING CASH FLOW | -157.18M | -117.36M | -228.82M | 6.69M | -93.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.17M | -7.97M | -9.82M | -9.57M | -590.00K | |||
| Other Investing Activity | 142.63M | 18.56M | 92.25M | 73.65M | -158.30M | |||
| INVESTING CASH FLOW | 141.47M | 10.58M | 82.43M | 64.09M | -158.89M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 50.52M | 25.70M | -950.00K | N/A | |||
| Stock Issued/Repurchased | 28.67M | 21.19M | 103.90M | 2.13M | 283.52M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 19.90M | |||
| FINANCING CASH FLOW | -85.70M | 71.70M | 129.60M | 1.18M | 303.42M | |||
| Exchange Rate Effect | N/A | 2.00K | 0.00 | 0.00 | N/A | |||
| CHANGE IN CASH | -101.42M | -35.07M | -16.79M | 71.96M | 50.92M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -157.18M | -117.36M | -228.82M | 6.69M | -93.61M | |||
| Capital Expenditure | -1.17M | -7.97M | -9.82M | -9.57M | -590.00K | |||
| FREE CASH FLOW | -158.35M | -125.33M | -238.64M | -2.88M | -94.20M | |||
All data in USD